Nobivac KC deguna pilieni, liofilizāts un šķīdinātājs suspensijas pagatavošanai suņiem
Nobivac KC deguna pilieni, liofilizāts un šķīdinātājs suspensijas pagatavošanai suņiem
Authorised
- Bordetella bronchiseptica, strain B-C2, Live
- Canine parainfluenza virus, strain Cornell, Live
Product identification
Medicine name:
Nobivac KC deguna pilieni, liofilizāts un šķīdinātājs suspensijas pagatavošanai suņiem
Active substance:
- Bordetella bronchiseptica, strain B-C2, Live
- Canine parainfluenza virus, strain Cornell, Live
Target species:
-
Dog
Route of administration:
-
Nasal use
Product details
Active substance and strength:
-
Bordetella bronchiseptica, strain B-C2, Live501187.00/Colony forming unit1.00unit(s)
-
Canine parainfluenza virus, strain Cornell, Live630957.00/50% tissue culture infectious dose1.00unit(s)
Pharmaceutical form:
-
Nasal drops, lyophilisate and solvent for suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AF
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Latvia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/NRP/02/1487
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 23/03/2026